TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 79 filers reported holding TRINITY BIOTECH PLC in Q2 2016. The put-call ratio across all filers is 3.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $4,000 | -20.0% | 700 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $5,000 | -44.4% | 700 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $9,000 | +12.5% | 700 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $8,000 | 0.0% | 700 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $8,000 | 0.0% | 700 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $8,000 | 0.0% | 700 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $8,000 | -38.5% | 700 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $13,000 | 0.0% | 700 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $13,000 | +8.3% | 700 | 0.0% | 0.00% | +100.0% |
| Q4 2014 | $12,000 | -58.6% | 700 | -50.0% | 0.00% | -50.0% |
| Q3 2014 | $29,000 | +81.2% | 1,400 | +100.0% | 0.00% | 0.0% |
| Q2 2014 | $16,000 | -5.9% | 700 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $17,000 | -5.6% | 700 | 0.0% | 0.00% | -33.3% |
| Q4 2013 | $18,000 | +20.0% | 700 | 0.0% | 0.00% | +50.0% |
| Q3 2013 | $15,000 | +25.0% | 700 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $12,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 639,291 | $14,723,000,000 | 6.49% |
| ACK Asset Management | 684,655 | $15,768,000 | 4.74% |
| GOLDMAN CAPITAL MANAGEMENT INC | 304,690 | $7,017,000 | 3.48% |
| Paradice Investment Management LLC | 239,138 | $5,507,000 | 1.64% |
| Park West Asset Management LLC | 520,770 | $11,993,000 | 1.56% |
| RK Capital | 323,279 | $7,445,000 | 1.48% |
| Adirondack Research & Management Inc. | 184,638 | $4,252,000 | 1.44% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 861,625 | $19,843,000 | 1.07% |
| Pier Capital, LLC | 251,917 | $5,802,000 | 0.82% |
| Benchmark Capital Advisors | 56,954 | $1,312,000 | 0.82% |